Jun Deng

2.0k citations

75 papers · 1.4k indexed · h-index 24

Impact in

Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation

Papers in ⓘ

Molecular Biology 35
- Circular RNAs in diseases 12
- RNA modifications and cancer 8
- RNA Research and Splicing 4
Cancer Research 28
- Cancer-related molecular mechanisms research 19
- MicroRNA in disease regulation 15

Co-authors: Jianping Xiong (27 shared papers)Xiaojun Xiang (15 shared papers)Jun Chen (11 shared papers)Ling Zhang (4 shared papers)Feng Miao (6 shared papers)Junhe Li (8 shared papers)Feng Yu (6 shared papers)Lei Wan (3 shared papers)
Journals: Scientific Reports (4 papers)Biochemical and Biophysical Research Communications (4 papers)Tumor Biology (3 papers)Journal of Cellular and Molecular Medicine (3 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: China United States Australia

In The Last Decade

Jun Deng

64 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jun Deng

Since Specialization

Citations

This map shows the geographic impact of Jun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Deng more than expected).

Fields of papers citing papers by Jun Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Deng. The network helps show where Jun Deng may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Deng Line = papers co-authored together Jun Deng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro Biochemical and Biophysical Research Communications ·Jun Deng, Lei Wan, Jian-Chun Fu, Ling Zhang, Junhe Li, Jianping Xiong	2013	102
2	miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1 Biochemical and Biophysical Research Communications ·Luying Wan, Jun Deng, Xiaojun Xiang, Ling Zhang, Feng Yu, Jun Chen, Zhe Sun, Feng Miao, Jianping Xiong	2014	87
3	The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients Biomedicine & Pharmacotherapy ·Jun Deng, Yujia Liang, Chunfeng Liu, Shengdong He, Songping Wang	2015	85
4	TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. PubMed ·Feng Qiu, Jianping Xiong, Jun Deng, Xiaojun Xiang	2015	65
5	MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1 Cellular Physiology and Biochemistry ·Xiaojun Xiang, Jun Deng, Yawen Liu, Luying Wan, Feng Miao, Jun Chen, Jianping Xiong	2015	63
6	Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway Oncotarget ·Jun Deng, Lei Wan, Xiaojun Xiang, Ling Zhang, Jun Lei, Yu Gong, Meijiao Song, Yi Wang, Ziling Fang, Feng Yu, Feng Miao, Ze Sun, Jun Chen, Zhengyu Zhan, Jianping Xiong	2016	59
7	MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway Gene ·Li Li, Jianguo Zhao, Shanshan Huang, Yi Wang, Lingling Zhu, Yuan Cao, Jianping Xiong, Jun Deng	2017	52
8	MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1 Tumor Biology ·Jun Deng, Lei Wan, Xiaojun Xiang, Ling Zhang, Feng Yu, Jun Chen, Feng Miao, Jianping Xiong	2015	50
9	miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3 International Journal of Molecular Medicine ·Jun Chen, Chao Zhou, Junhe Li, Xiaojun Xiang, Ling Zhang, Jun Deng, Jianping Xiong	2018	50
10	Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile Tumor Biology ·Dong Li, Jun Deng, Ze-Min Sun, An-Ping Pan, Xiaojun Xiang, Ling Zhang, Feng Yu, Jun Chen, Zhe Sun, Feng Miao, Jianping Xiong	2015	42
11	TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway Oncology Letters ·Ziling Fang, Jun Deng, Ling Zhang, Xiaojun Xiang, Feng Yu, Jun Chen, Feng Miao, Jianping Xiong	2017	40
12	SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer eLife ·Ziling Fang, Bo Cao, Jun‐Ming Liao, Jun Deng, Kevin D. Plummer, Peng Liao, Tao Liu, Wensheng Zhang, Kun Zhang, Li Li, David A. Margolin, Shelya X. Zeng, Jianping Xiong, Hua Lu	2018	40
13	A comparison of the prognosis of papillary and clear cell renal cell carcinoma Medicine ·Jun Deng, Lei Li, Haimei Xia, Ju Guo, Xin Wu, Xiaorong Yang, Yan‐Yan Hong, Qingke Chen, Jieping Hu	2019	40
14	LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway Biochemical and Biophysical Research Communications ·Zhen Liu, Yangyang Yao, Shanshan Huang, Li Li, Bailing Jiang, Hui Guo, Lei Wan, Jianping Xiong, Jun Deng	2018	39
15	Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways Gene ·Lingling Zhu, Shanshan Huang, Junhe Li, Jun Chen, Yangyang Yao, Li Li, Hui Guo, Xiaojun Xiang, Jun Deng, Jianping Xiong	2020	33
16	Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance Tumor Biology ·Jun Deng, Yi Wang, Jun Lei, Lei Wan, Jian Xiong	2017	31
17	Systematic review with meta‐analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases Alimentary Pharmacology & Therapeutics ·Hongsheng Yang, Bingyang Li, Qin Guo, Jian Tang, Bo Peng, Ni Ding, Miao Li, Qingfang Yang, Zicheng Huang, Na Diao, Xia Zhu, Jun Deng, Huili Guo, P. Hu, Kang Chao, Xiang Gao	2022	30
18	MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR Technology in Cancer Research & Treatment ·Yang Liu, Shutao Zhu, Xiao Wang, Jun Deng, Weihua Li, Peng Zhang, Bingshan Liu	2015	29
19	Biodegradation of Benzo[a]pyrene by Arthrobacter oxydans B4 Pedosphere ·Hui Peng, Hua Yin, Jun Deng, Jinshao Ye, Shuona Chen, Bao-Yan He, Na Zhang	2012	28
20	Orally administered CCR2 selective inhibitor CCX872-b clinical trial in pancreatic cancer. Journal of Clinical Oncology ·Marcus Smith Noel, Aram F. Hezel, David C. Linehan, Andrea Wang‐Gillam, Ferry A.L.M. Eskens, Stefan Sleijfer, Ingrid M.E. Desar, Frans Erdkamp, Johanna W. Wilmink, J. Nathaniel Diehl, Antonia Potarca, Niky Zhao, Jun Deng, Lisa Lohr, Shichang Miao, Israel Charo, Rajinder Singh, Thomas J. Schall, Pirow Bekker	2017	27

About Jun Deng

Jun Deng is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 75 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (12 papers), RNA modifications and cancer (8 papers), Hippo pathway signaling and YAP/TAZ (8 papers), Bladder and Urothelial Cancer Treatments (5 papers), Ferroptosis and cancer prognosis (5 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (743 citations), Molecular Biology (995 citations), Oncology (226 citations), Cell Biology (113 citations) and Immunology (146 citations). Jun Deng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianping Xiong, Xiaojun Xiang, Jun Chen, Ling Zhang, Feng Miao, Junhe Li, Feng Yu, Lei Wan, Shanshan Huang and Chunfeng Liu. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, Tumor Biology, Journal of Cellular and Molecular Medicine and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact